Surgery for post‐vitrectomy cataract
Referencias
References to studies excluded from this review
Ahmadieh H, Moradian S, Faghihi H, Parvaresh MM, Ghanbari H, Mehryar M, et al. Anatomic and visual outcomes of scleral buckling versus primary vitrectomy in pseudophakic and aphakic retinal detachment: six‐month follow‐up results of a single operation‐‐report no. 1. Ophthalmology 2005;112(8):1421‐9.
Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Khaw PT, et al. Adjuvant 5‐fluorouracil and heparin prevents proliferative vitreoretinopathy: results from a randomized, double‐blind, controlled clinical trial. Ophthalmology 2001;108(7):1179‐83.
Batman C, Cekic O. Vitrectomy with silicone oil or long‐acting gas in eyes with giant retinal tears: long‐term follow‐up of a randomized clinical trial. Retina 1999;19(3):188‐92.
Blankenship GW. The lens influence on diabetic vitrectomy results. Report of a prospective randomized study. Archives of Ophthalmology 1980;98(12):2196‐8.
The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial‐‐Diabetic Retinopathy Vitrectomy Study Report 3. The Diabetic Retinopathy Vitrectomy Study Research Group. Ophthalmology 1988;95(10):1307‐20.
The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four‐year results of a randomized trial: Diabetic Retinopathy Vitrectomy Study Report 5. Archives of Ophthalmology 1990;108(7):958‐64.
The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two‐year results of a randomized trial. Diabetic Retinopathy Vitrectomy Study report 2. The Diabetic Retinopathy Vitrectomy Study Research Group. Archives of Ophthalmology 1985;103(11):1644‐52.
Ehud A, Varda C, Joseph M, Giora T. Management of complicated retinal detachment by vitrectomy and silicone oil injection. Metabolic, Pediatric, and Systemic Ophthalmology 1988;11(1‐2):63‐6.
Ezra E, Gregor ZJ. Surgery for idiopathic full‐thickness macular hole: two‐year results of a randomized clinical trial comparing natural history, vitrectomy, and vitrectomy plus autologous serum: Morfields Macular Hole Study Group RAeport no. 1. Archives of Ophthalmology 2004;122(2):224‐36.
Freeman WR, Azen SP, Kim JW, el‐Haig W, Mishell DR, Bailey I. Vitrectomy for the treatment of full‐thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group. Archives of Ophthalmology 1997;115(1):11‐21.
Haimann MH, Abrams GW. Prevention of lens opacification during diabetic vitrectomy. Ophthalmology 1984;91(2):116‐21.
Abrams GW, Azen SP, McCuen BW, Flynn HW, Lai MY, Ryan SJ. Vitrectomy with silicone oil or long‐acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long‐term follow‐up. Silicone Study report 11. Archives of Ophthalmology 1997;115(3):335‐44.
Anonymous. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 2. Archives of Ophthalmology 1992;110(6):780‐92.
Anonymous. Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1. Archives of Ophthalmology 1992;110(6):770‐9.
Additional references
Ahfat FG, Yuen CH, Groenewald CP. Phacoemulsification and intraocular lens implantation following pars plana vitrectomy: a prospective study. Eye 2003;17(1):16‐20.
Barañano AE, Wu J, Mazhar K, Azen SP, Varma R, Los Angeles Latino Eye Study Group. Visual acuity outcomes after cataract extraction in adult Latinos. The Los Angeles Latino Eye Study. Ophthalmology 2008;115(5):815‐21.
Benson WE. Vitrectomy in clinical ophthalmology. In: Duane TD editor(s). Duane's Clinical Ophthalmology. Vol. 5, Philadelphia: Lippincott, 1988:15‐7.
Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, et al. An international classification and grading system for age‐related maculopathy and age‐related macular degeneration. The International ARM Epidemiological Study Group. Survey of Ophthalmology 1995;39(5):367‐74.
Biro Z, Kovacs B. Results of cataract surgery in previously vitrectomized eyes. Journal of Cataract and Refractive Surgery 2002;28(6):1003‐6.
Cheng L, Azen SP, El‐Bradey MH, Scholz BM, Chaidhawangul S, Toyoguchi M, et al. Duration of vitrectomy and postoperative cataract in the vitrectomy for macular hole study. American Journal of Ophthalmology 2001;132(6):881‐7.
Cherfan GM, Michels RG, de Bustros S, Enger C, Glaser BM. Nuclear sclerotic cataract after vitrectomy for idiopathic epiretinal membranes causing macular pucker. American Journal of Ophthalmology 1991;111(4):434‐8.
de Bustros S, Thompson JT, Michels RG, Enger C, Rice TA, Glaser BM. Nuclear sclerosis after vitrectomy for idiopathic epiretinal membrane. American Journal of Ophthalmology 1988;105(2):160‐4.
Anonymous. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(Suppl 5):823‐33.
Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Holekamp NM, Shui YB, Beebe DC. Vitrectomy surgery increases oxygen exposure to the lens: a possible mechanism for nuclear cataract formation. American Journal of Ophthalmology 2005;139(2):302‐10.
Machemer R, Buettner H, Norton EWD, Parel JM. Vitrectomy: A pars plana approach. Transactions of the American Academy of Ophthalmology and Otolaryngology 1971;75(4):813‐20.
Melberg NS, Thomas MA. Nuclear sclerotic cataract after vitrectomy in patients under 50 years of age. Ophthalmology 1995;102(10):1466‐71.
Ogura Y, Takanashi T, Ishigooka H, Ogino N. Quantitative analysis of lens changes after vitrectomy by fluorophotometry. American Journal of Ophthalmology 1991;111(2):179‐83.
Palmquist BM, Philipson B, Fagerholm P. Nuclear cataract ‐ a microradiographic study. Acta Ophthalmologica 1988;66(6):671‐7.
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2013.
Hawkins BS, Bressler NM, Miskala PH, Bressler SB, Holekamp NM, Marsh MJ, et al. Surgery for subfoveal choroidal neovascularization in age‐related macular degeneration: ophthalmic findings: SST report no.11. Ophthalmology 2004;111(11):1967‐80.
Bressler NM, Bressler SB, Childs AL, Haller JA, Hawkins BS, Lewis H, et al. Surgery for hemorrhagic choroidal neovascular lesions of age‐related macular degeneration: Ophthalmic findings. SST report no. 13. Ophthalmology 2004;111(11):1993‐2006.
Hawkins BS, Bressler NM, Bressler SB, Davidorf FH, Hoskins JC, Marsh MJ, et al. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9. Archives of Ophthalmology 2004;122(11):1597‐611.
References to other published versions of this review
Do DV, Hawkins BS, Gichuhi S. Surgery for post‐vitrectomy cataract. Cochrane Database of Systematic Reviews 1, Issue 2007. [DOI: 10.1002/14651858.CD006366]
Do DV, Hawkins B, Gichuhi S, Vedula SS. Surgery for post‐vitrectomy cataract. Cochrane Database of Systematic Reviews 2008, Issue 3. [DOI: 10.1002/14651858.CD006366.pub2]
Characteristics of studies
Characteristics of excluded studies [ordered by study ID]
| Study | Reason for exclusion |
| RCT, not post‐vitrectomy patients | |
| RCT, post‐vitrectomy patients, not for cataract surgery | |
| RCT, not post‐vitrectomy patients, not cataract surgery | |
| RCT, not post‐vitrectomy patients, not for cataract surgery | |
| RCT or CCT, not post‐vitrectomy patients, not cataract surgery | |
| RCT, not post‐vitrectomy patients, not for cataract surgery | |
| RCT, not post‐vitrectomy patients, not for cataract surgery | |
| RCT, not post‐vitrectomy patients, not for cataract surgery | |
| RCT, not post‐vitrectomy patients, not for cataract surgery | |
| RCT for post‐vitrectomy patients, not for cataract surgery |
CCT: controlled clinical trial
RCT: randomized controlled trial
Figuras y tablas -
Figure 1
Study flow diagram.
